CG
PTLA

Cutler Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cutler Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-35,000
Closed -$127K – 4985
2019
Q4 		$127K Hold
35,000
– – 0.01% 1075
2019
Q3 		$114K Buy
35,000
+5,000
+17% +$140K 0.01% 1003
2019
Q2 		$129K Buy
30,000
+4,700
+19% +$147K 0.01% 961
2019
Q1 		$78K Buy
+25,300
New +$730K 0.01% 1149
2018
Q4 		– Sell
-21,200
Closed -$267K – 4919
2018
Q3 		$267K Buy
21,200
+2,500
+13% +$81.6K 0.02% 710
2018
Q2 		$158K Sell
18,700
-21,700
-54% -$830K 0.01% 894
2018
Q1 		$304K Buy
40,400
+11,800
+41% +$518K 0.03% 614
2017
Q4 		$204K Sell
28,600
-12,800
-31% -$647K 0.01% 946
2017
Q3 		$348K Sell
41,400
-21,200
-34% -$1.24M 0.01% 846
2017
Q2 		$165K Buy
62,600
+53,700
+603% +$2.15M 0.01% 1439
2017
Q1 		$68K Sell
8,900
-22,300
-71% -$710K ﹤0.01% 2098
2016
Q4 		$164K Buy
31,200
+4,700
+18% +$91.8K 0.01% 1467
2016
Q3 		$99K Buy
26,500
+24,700
+1,372% +$580K ﹤0.01% 1815
2016
Q2 		$6K Sell
1,800
-50,600
-97% -$1.25M ﹤0.01% 4826
2016
Q1 		$144K Buy
52,400
+46,700
+819% +$1.48M 0.01% 1273
2015
Q4 		$44K Buy
+5,700
New +$276K ﹤0.01% 2611

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cutler Group's PTLA Position: Q2 2020 in Review

Cutler Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,500 shares — an estimated $10K sold.

Cutler Group first reported a position in PTLA in Q4 2015 and held it in 18 quarters. The position peaked at $1.77M in Q3 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Cutler Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 1,500 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $10K.
  • Cutler Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Portola Pharmaceuticals, Inc. position peaked at $1.77M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.